Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 11, Issue 4, Pages 1069
Publisher
MDPI AG
Online
2022-02-21
DOI
10.3390/jcm11041069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1b Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
- (2021) David W Andrews et al. CLINICAL CANCER RESEARCH
- Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma
- (2021) Pashayar P. Lookian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
- (2021) Fan Yang et al. Nature Communications
- Treating ICB-resistant glioma with anti-CD40 and mitotic spindle checkpoint controller BAL101553 (lisavanbulin)
- (2021) Vassilis Genoud et al. JCI Insight
- Adding high-dose celecoxib to increase effectiveness of standard glioblastoma chemoirradiation
- (2021) R.E. Kast ANNALES PHARMACEUTIQUES FRANCAISES
- Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma
- (2020) Yolanda Pires-Afonso et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reprogramming of macrophages employing gene regulatory and metabolic network models
- (2020) Franziska Hörhold et al. PLoS Computational Biology
- Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
- (2020) Ana Rita Pombo Antunes et al. eLife
- Tumor-derived exosomes in the regulation of macrophage polarization
- (2020) Mirza S. Baig et al. INFLAMMATION RESEARCH
- Repolarization of glioblastoma macrophage cells using non-agonistic Dectin-1 ligand encapsulating TLR-9 agonist: plausible role in regenerative medicine against brain tumor
- (2020) Rohit Kumar Tiwari et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance
- (2020) Renee B. Chang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma
- (2020) Brittany L. Voth et al. JOURNAL OF NEURO-ONCOLOGY
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
- (2020) Yajing Mi et al. Frontiers in Immunology
- Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer
- (2020) Mehdi Chaib et al. Frontiers in Cell and Developmental Biology
- Microglial TLR9: Plausible Novel Target for Therapeutic Regime Against Glioblastoma Multiforme
- (2020) Rohit Kumar Tiwari et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Immune suppression in gliomas
- (2020) Matthew M. Grabowski et al. JOURNAL OF NEURO-ONCOLOGY
- Identification of biomarkers associated with extracellular vesicles based on an integrative pan-cancer bioinformatics analysis
- (2020) Qiang Wang et al. MEDICAL ONCOLOGY
- Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
- (2020) Shin Foong Ngiow et al. Frontiers in Immunology
- Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
- (2020) Tsubasa Miyazaki et al. Cancers
- LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
- (2020) Anne Berberich et al. Frontiers in Oncology
- Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
- (2020) Catalina Lee-Chang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Microglia-Centered Combinatorial Strategies Against Glioblastoma
- (2020) Tomás A. Martins et al. Frontiers in Immunology
- Glioblastoma Immune Landscape and the Potential of New Immunotherapies
- (2020) Thomas Daubon et al. Frontiers in Immunology
- Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
- (2020) Zening Zheng et al. Journal for ImmunoTherapy of Cancer
- Macrophage-based approaches for cancer immunotherapy
- (2020) Nicholas R. Anderson et al. CANCER RESEARCH
- Clinical implication of cellular vaccine in glioma: current advances and future prospects
- (2020) Yuanliang Yan et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
- (2019) William Tomaszewski et al. CLINICAL CANCER RESEARCH
- Glioblastoma-Derived IL-6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
- (2019) Jonathan B Lamano et al. CLINICAL CANCER RESEARCH
- The expression of CD40 correlates negatively with overall- and progression free survival of low- and high-grade gliomas
- (2019) Jan-Michael Werner et al. World Neurosurgery
- Tumor-associated macrophage related interleukin-6 in cerebrospinal fluid as a prognostic marker for glioblastoma
- (2019) Tatsuo Hori et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors
- (2019) Andy S. Ding et al. Frontiers in Immunology
- CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy
- (2019) Zhengming Xiong et al. CLINICAL CANCER RESEARCH
- Role of myeloid cells in the immunosuppressive microenvironment in gliomas
- (2019) Chiara V. Locarno et al. IMMUNOBIOLOGY
- Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology
- (2019) David H. Gutmann et al. NEURON
- Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
- (2019) Laura Lorenzo-Sanz et al. Cancer Microenvironment
- Antigen-loaded monocyte administration induces potent therapeutic antitumor T cell responses
- (2019) Min-Nung Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
- (2019) Eleni-Kyriaki Vetsika et al. Cells
- Microglial Lectins in Health and Neurological Diseases
- (2018) Jian Jing Siew et al. Frontiers in Molecular Neuroscience
- Emerging Cellular Therapies for Cancer
- (2018) Sonia Guedan et al. Annual Review of Immunology
- Immunotherapy for Glioblastoma: Adoptive T-cell Strategies
- (2018) Bryan D. Choi et al. CLINICAL CANCER RESEARCH
- Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
- (2018) Ren-You Pan et al. Journal of Immunology Research
- Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial
- (2018) Johanna Buchroithner et al. Cancers
- Microglia-glioma cross-talk a two way approach to new strategies against glioma
- (2017) Cataldo Arcuri Frontiers in Bioscience-Landmark
- Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node
- (2017) Lifang Cheng et al. MOLECULAR THERAPY
- Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin
- (2017) Richard E Kast et al. TUMOR BIOLOGY
- IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge
- (2017) Olga Spadaro et al. Cell Reports
- Quantitative expression of serum biomarkers involved in angiogenesis and inflammation, in patients with glioblastoma multiforme: Correlations with clinical data
- (2017) Roxana Chiorean et al. Cancer Biomarkers
- Local convection-enhanced delivery of an anti-CD40 agonistic monoclonal antibody induces antitumor effects in mouse glioma models
- (2016) Takuhiro Shoji et al. NEURO-ONCOLOGY
- Microglia and brain macrophages: An update
- (2016) Atsushi Sasaki NEUROPATHOLOGY
- A reappraisal of macrophage polarization in glioblastoma: Histopathological and immunohistochemical findings and review of the literature
- (2016) Chiara Mignogna et al. PATHOLOGY RESEARCH AND PRACTICE
- Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen
- (2016) Michael Salacz et al. OncoTargets and Therapy
- Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
- (2016) Robert L. Bowman et al. Cell Reports
- Immunological Evasion in Glioblastoma
- (2016) Roxana Magaña-Maldonado et al. Biomed Research International
- Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide
- (2015) Mélanie Morin-Brureau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD40/CD40L expression correlates with the survival of patients with glioblastomas and an augmentation in CD40 signaling enhances the efficacy of vaccinations against glioma models
- (2015) Masashi Chonan et al. NEURO-ONCOLOGY
- Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients
- (2015) Larry A. Harshyne et al. NEURO-ONCOLOGY
- Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm
- (2014) Larry A. Harshyne et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells
- (2014) Annett Müller et al. INTERNATIONAL JOURNAL OF CANCER
- ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
- (2014) Thomas Condamine et al. JOURNAL OF CLINICAL INVESTIGATION
- Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
- (2013) M. Prosniak et al. CLINICAL CANCER RESEARCH
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation
- (2013) Anuradha Ray et al. Frontiers in Cellular and Infection Microbiology
- Interleukins in glioblastoma pathophysiology: implications for therapy
- (2012) YT Yeung et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-IL-6 receptor mAb eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T-cell responses
- (2012) Kentaro Sumida et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
- (2010) Xinmei Zhu et al. JOURNAL OF NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More